Trial Parameters
Brief Summary
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
Eligibility Criteria
Inclusion Criteria: * Subject residents in Zhongshan or Wuzhou City; * Subject has no medical record of prevalent cancer; * Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures. Exclusion Criteria: * Subject has heavy cardiovascular, liver, or kidney disease; * Subject has prevalent cancer.